CAR-T therapy’s complications, as well as its benefits, become clearer in ‘flurry’ of cancer studies
Researchers were perplexed when the Food and Drug Administration announced it was investigating whether CAR-T therapy, one of ...
Health care is undergoing an important and well-needed shift from a one-size-fits-all approach to more personalized, precise, ...
Grave warnings of a crisis in maternal deaths are being slightly eroded by articles suggesting that advocates overreached and ...
This week, the late National Hockey League veteran Greg Johnson was diagnosed with chronic traumatic encephalopathy, or CTE. Johnson died by suicide five years ago at the age of 48, having played 14 ...
Alcohol, along with the better-known risks of smoking and obesity, is one of the "potentially modifiable risk factors" ...
Why are pharma companies cutting more staff than cash-strapped biotechs? And who will Pfizer scout out as its next science ...
In what could be a lifeline for a new crop of health tech startups, Medicare proposes paying for digital mental health ...
Pfizer said Thursday that it plans to advance a new, once-a-day formulation of its experimental obesity drug danuglipron, ...
The U.S. Food and Drug Administration rejected Novo Nordisk’s weekly insulin for treating diabetes in a rare setback for the ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Schools shouldn't be caught off guard if H5N1 jumps from animals to humans. To protect children, they need to begin preparing ...
Pain medicine in the U.S. is failing patients and clinicians, largely due to the CDC's faulty narrative and the DEA's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback